Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-859X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial ; volume:10 ; number:1 ; day:11 ; month:4 ; year:2011 ; pages:1-10 ; date:12.2011
Annals of general psychiatry ; 10, Heft 1 (11.4.2011), 1-10, 12.2011
- Urheber
-
Alphs, Larry
Bossie, Cynthia A.
Sliwa, Jennifer K.
Ma, Yi-Wen
Turner, Norris
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1744-859X-10-12
- URN
-
urn:nbn:de:101:1-2019071902283578192786
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Alphs, Larry
- Bossie, Cynthia A.
- Sliwa, Jennifer K.
- Ma, Yi-Wen
- Turner, Norris
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Correction: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
Correction: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
Three-year clinical experience with the long-acting injectable formulation of the atypical antipsychotic risperidone
Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy